Skip to Content


Foreign-Trade Zone 59, Temporary/Interim Manufacturing Authority, Novartis Consumer Health, Inc., (Pharmaceutical Product Manufacturing); Notice of Approval

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

On January 12, 2012, the Executive Secretary of the Foreign-Trade Zones (FTZ) Board filed an application submitted by the Lincoln Foreign Trade Zone, Inc., grantee of FTZ 59, requesting temporary/interim manufacturing (T/IM) authority, on behalf of Novartis Consumer Health, Inc., to manufacture pharmaceutical products under FTZ procedures within FTZ 59—Sites 3 and 4, in Lincoln, Nebraska.

The application was processed in accordance with T/IM procedures, as authorized by FTZ Board Orders 1347 (69 FR 52857, 8/30/04) and 1480 (71 FR 55422, 9/22/06), including notice in the Federal Register inviting public comment (77 FR 4758, 1/31/2012). The FTZ staff examiner reviewed the application and determined that it meets the criteria for approval under T/IM procedures. Pursuant to the authority delegated to the FTZ Board Executive Secretary in the above-referenced Board Orders, the application is approved, effective this date, until March 27, 2014, subject to the FTZ Act and the Board's regulations, including Section 400.28.

Dated: March 27, 2012.

Andrew McGilvray,

Executive Secretary.

[FR Doc. 2012-9357 Filed 4-17-12; 8:45 am]